Michal J. Schinwelski

Gdansk, PM, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Resolving Complex Structural Variants in Undiagnosed Rare Movement Disorders via Multimodal Genomics and Multi-omics.

Resolving Complex Structural Variants in Undiagnosed Rare Movement Disorders via Multimodal Genomics and Multi-omics.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 28, 2026

Beyond SGCE: expanding the clinical and molecular spectrum of KCTD17- and KCNN2-related myoclonus-dystonia.

Beyond SGCE: expanding the clinical and molecular spectrum of KCTD17- and KCNN2-related myoclonus-dystonia.

Journal: Frontiers in neurology

Published: October 19, 2025

ACTB-associated dystonia-deafness syndrome with good response to DBS GPi revisited.

ACTB-associated dystonia-deafness syndrome with good response to DBS GPi revisited.

Journal: Clinical parkinsonism & related disorders

Published: October 11, 2025

Anterior attentional system efficacy in Parkinson's disease: a cross-sectional study in Poland.

Anterior attentional system efficacy in Parkinson's disease: a cross-sectional study in Poland.

Journal: Frontiers in human neuroscience

Published: August 29, 2025

Correction: Sławek et al. Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia. Toxins 2025, 17, 375.

Correction: Sławek et al. Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia. Toxins 2025, 17, 375.

Journal: Toxins

Published: August 25, 2025

Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia.

Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia.

Journal: Toxins

Published: May 21, 2025

New Progressive Generalized Dystonia Phenotype in a Patient with NBEA-Related Neurodevelopmental Disease.

New Progressive Generalized Dystonia Phenotype in a Patient with NBEA-Related Neurodevelopmental Disease.

Journal: Movement disorders clinical practice

Published: February 04, 2025

Levodopa and dopamine agonist phobia in Parkinson's Disease - does it really matter? A survey on treatment patterns in Polish tertiary centres.

Levodopa and dopamine agonist phobia in Parkinson's Disease - does it really matter? A survey on treatment patterns in Polish tertiary centres.

Journal: Neurologia i neurochirurgia polska

Published: October 22, 2024

A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes.

A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes.

Journal: Genes

Published: November 11, 2022

Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study.

Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study.

Journal: Parkinsonism & related disorders

Published: August 22, 2022

Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity.

Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity.

Journal: Journal of rehabilitation medicine

Published: July 08, 2022

The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease.

The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease.

Journal: Neuromodulation : journal of the International Neuromodulation Society

Published: January 13, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026